Medicaid policies that require patients to undergo counseling in order to receive medications to quit smoking, in fact end up affecting the use of these medications, according to a new study.
Medicaid policies that require patients to undergo counseling in order to receive medications to quit smoking, in fact end up affecting the use of these medications, according to a new study. Put simply, if the Medicaid beneficiaries possess incomplete information about the tobacco-cessation programs, the counseling sessions do no good to smokers who want to quit and become a barrier to their efforts.
The study, published in the CDC’s Preventing Chronic Disease journal, talks about the barriers created by Medicaid programs for smokers who want to quit. Leighton Ku, PhD, MPH, professor of health policy and management at Milken Institute School of Public Health, Washington, DC, and fellow colleagues compiled the report to highlight the irony of such Medicaid policies.
“Many organizations encourage coverage of all FDA-approved cessation medications and counseling and elimination of barriers that might limit access,” the authors wrote. “However, these benefits may go unused if patients and physicians are unaware that they are available or are not sufficiently engaged to attempt quitting. Fewer than half of smokers in Medicaid-managed care plans reported that their physicians offered assistance, such as medications or counseling, to quit.”
Smoking—A Double Whammy
In US, smoking is the leading cause of preventable illness and disease. Furthermore, almost one-third of adults covered by Medicaid, the nation’s largest health insurance program, smokes.
By quitting, smokers can drastically reduce the risk of deadly smoking-related diseases such as lung cancer. And such policies that help smokers quit are an investment that pays off for the Medicaid program, because tobacco-related diseases cost the Medicaid program a huge amount every year. If smokers quit, a major chunk of these health expenses can be prevented.
“Policies and programs that empower low-income Medicaid smokers to quit could improve their health and help reduce healthcare costs,” Ku said in a statement.
Counseling: A Building Block or a Hurdle?
When the authors examined state-level differences in the use of anti-smoking medications by Medicaid patients between 2010 and 2014, they found that the counseling requirement in fact became a barrier to quitting smoking.
The counseling sessions are designed to help smokers quit. However, the benefits may go unused if patients and physicians are unaware of their availability in the first place. More than 50% of smokers in Medicaid-managed care plans said that their physicians were not as invested in offering assistance in terms of medications or counseling, to quit.
It is imperative for states to increase efforts to develop more comprehensive coverage and reduce barriers to coverage because:
By empowering patients and providers to increase awareness of cessation benefits and undertake the difficult challenge of quitting, states can drastically reduce healthcare costs while positively impacting health. This would also prevent relapses.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More